Given the occurrence of PIK3CA mutations in all stages of thyroid carcinoma, it supports the implication of the PI3K/AKT signaling pathway in both the initiation and progressive dedifferentiation of the disease (27,28,29). The gene discussed is AKT1; the disease is thyroid gland carcinoma.